TipRanks
Advertisement
Advertisement
Alaunos Reports Positive Preclinical Metabolic Data for ALN1003
PremiumCompany AnnouncementsAlaunos Reports Positive Preclinical Metabolic Data for ALN1003
4M ago
Alaunos Highlights New Preclinical Data for Obesity Therapy
Premium
Company Announcements
Alaunos Highlights New Preclinical Data for Obesity Therapy
4M ago
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
Premium
The Fly
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
4M ago
Alaunos Updates Governance, Ends Cantor Advisory Agreement
PremiumCompany AnnouncementsAlaunos Updates Governance, Ends Cantor Advisory Agreement
9M ago
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
Premium
Company Announcements
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
9M ago
Alaunos Therapeutics files to sell 327,740 shares of common for holders
Premium
The Fly
Alaunos Therapeutics files to sell 327,740 shares of common for holders
11M ago
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
PremiumCompany AnnouncementsAlaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
1y ago
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
Premium
Company Announcements
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
1y ago
Alaunos Therapeutics Announces Departure of Melinda Lackey
Premium
Company Announcements
Alaunos Therapeutics Announces Departure of Melinda Lackey
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―